Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 81551-81600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05700929
Evaluation of a Communication Skills Training for Nurses
NAActive, not recruiting
207 participants
Started: Nov 14, 2022 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT03886675
Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection
NARecruiting
120 participants
Started: Nov 14, 2022 · Completed: Oct 31, 2024
4 conditions9 sponsors1 location
NCT05458713
The Effect of Laser Acupuncture in Different Meridians on the Autonomic Nervous System and Its Brain Mechanisms
NAActive, not recruiting
80 participants
Started: Nov 13, 2022 · Completed: Dec 31, 2024
4 conditions2 sponsors1 location
NCT05634681
Plan of the Day Radiotherapy
NARecruiting
190 participants
Started: Nov 13, 2022 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT04496895
The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults
NARecruiting
124 participants
Started: Nov 12, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06300684
Exploring CBTi's Dual Effect on Sleep, Diet, & Chrononutrition
NARecruiting
40 participants
Started: Nov 11, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor2 locations
NCT04925492
PET Imaging of Vaso-Occlusive Crisis (VOC) in SCD
PHASE1Recruiting
20 participants
Started: Nov 11, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05429463
Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC(neoSCORE Ⅱ)
PHASE3Recruiting
250 participants
Started: Nov 11, 2022 · Completed: Nov 11, 2029
1 condition1 sponsor1 location
NCT05394844
Diabetes Education With Real-time Continuous Glucose Monitoring
NAActive, not recruiting
120 participants
Started: Nov 11, 2022 · Completed: Nov 30, 2024
1 condition5 sponsors2 locations
NCT05646550
Antibody CC-1 in Men With Biochemical Recurrence of Prostate Cancer
PHASE1Recruiting
56 participants
Started: Nov 11, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05474027
Reducing Hypotensive Anesthesia Use with TXA During Orthognathic Surgery
PHASE4Enrolling by invitation
50 participants
Started: Nov 11, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04768920
Examining Feasibility and Acceptability of Telemedicine for Substance Use Disorder (SUD)
NAActive, not recruiting
50 participants
Started: Nov 11, 2022 · Completed: Feb 28, 2026
3 conditions1 sponsor1 location
NCT05839587
Transabdominal Preperitoneal Inguinal Hernia Repair
NAActive, not recruiting
150 participants
Started: Nov 11, 2022 · Completed: May 31, 2025
2 conditions1 sponsor1 location
NCT05634902
Implementation of Evidence-Based Practice for Dizziness
NAActive, not recruiting
80,000 participants
Started: Nov 11, 2022 · Completed: Mar 31, 2025
4 conditions4 sponsors1 location
NCT05628857
A Study of RC108-ADC in Subjects With Advanced Digestive System Malignant Tumor
PHASE2Active, not recruiting
240 participants
Started: Nov 11, 2022 · Completed: Oct 15, 2025
1 condition1 sponsor1 location
NCT05928936
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
PHASE2Recruiting
156 participants
Started: Nov 11, 2022 · Completed: Jun 1, 2028
1 condition2 sponsors2 locations
NCT05599724
PMA-FERTITHEQUE Biocollection
N/ARecruiting
250 participants
Started: Nov 11, 2022 · Completed: Aug 15, 2028
2 conditions1 sponsor1 location
NCT07139171
Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
N/ARecruiting
300 participants
Started: Nov 11, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05408221
the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma
PHASE2/PHASE3Recruiting
576 participants
Started: Nov 11, 2022 · Completed: Aug 1, 2026
1 condition1 sponsor5 locations
NCT06218784
A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.
PHASE1Recruiting
64 participants
Started: Nov 11, 2022 · Completed: Jul 29, 2024
7 conditions1 sponsor1 location
NCT06196606
Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary Infarction
NARecruiting
20 participants
Started: Nov 11, 2022 · Completed: Dec 12, 2024
3 conditions1 sponsor1 location
NCT05476770
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
PHASE1Recruiting
54 participants
Started: Nov 11, 2022 · Completed: Nov 11, 2027
11 conditions1 sponsor31 locations
NCT05654883
New York City Observational Study of Mpox Immunity
N/AEnrolling by invitation
174 participants
Started: Nov 11, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT05625490
Myocardial Perfusion Imaging Galmydar Rest/Stress
EARLY_PHASE1Recruiting
30 participants
Started: Nov 11, 2022 · Completed: Dec 1, 2025
1 condition3 sponsors1 location
NCT05620693
Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma
NARecruiting
20 participants
Started: Nov 11, 2022 · Completed: Dec 1, 2028
1 condition1 sponsor1 location
NCT05498428
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
PHASE2Recruiting
520 participants
Started: Nov 11, 2022 · Completed: Aug 17, 2027
1 condition1 sponsor110 locations
NCT05384587
Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia
PHASE2Active, not recruiting
34 participants
Started: Nov 11, 2022 · Completed: Oct 17, 2027
1 condition1 sponsor80 locations
NCT05734430
Genetics of Appendix Cancer Study
N/ARecruiting
700 participants
Started: Nov 11, 2022 · Completed: Nov 30, 2034
15 conditions1 sponsor1 location
NCT05590702
French Observational Study of Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in Real-World Settings
N/ARecruiting
1,000 participants
Started: Nov 11, 2022 · Completed: Dec 1, 2032
1 condition5 sponsors57 locations
NCT05520086
Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Nov 11, 2022 · Completed: Nov 11, 2024
4 conditions2 sponsors8 locations
NCT05639907
Miniscrew Stability and Peri-implant Inflammation When Precoated K21 vs Ethanol Control
NARecruiting
30 participants
Started: Nov 11, 2022 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT05372679
REDUCED 1 - Renal Denervation Using Ultrasonic Catheter EmitteD Energy Study /
NAActive, not recruiting
25 participants
Started: Nov 11, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor9 locations
NCT05527470
Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
PHASE3Recruiting
440 participants
Started: Nov 11, 2022 · Completed: Nov 11, 2027
1 condition6 sponsors2 locations
NCT05521802
A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2Recruiting
92 participants
Started: Nov 11, 2022 · Completed: Jul 31, 2037
1 condition1 sponsor1 location
NCT05368662
Quality of Life and Quality of Sleep Studies in Children with Home Care Ventilation in the West of France
NARecruiting
160 participants
Started: Nov 11, 2022 · Completed: Sep 24, 2026
2 conditions1 sponsor1 location
NCT05606068
A Novel Limb Cryocompression System for Prevention of Chemotherapy Induced Peripheral Neuropathy - Expansion Study
NARecruiting
80 participants
Started: Nov 11, 2022 · Completed: Nov 30, 2026
1 condition4 sponsors2 locations
NCT04319276
Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
PHASE1Active, not recruiting
26 participants
Started: Nov 11, 2022 · Completed: Oct 10, 2025
1 condition1 sponsor1 location
NCT05493475
Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants
NAActive, not recruiting
1,750 participants
Started: Nov 10, 2022 · Completed: Sep 30, 2025
3 conditions1 sponsor1 location
NCT05612607
Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological Malignancies
PHASE4Not yet recruiting
100 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05524311
Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)
PHASE2Recruiting
16 participants
Started: Nov 10, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor13 locations
NCT05513846
Brain Age and Sleep Architecture in Meditators
N/AActive, not recruiting
100 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05270733
Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
PHASE4Recruiting
56 participants
Started: Nov 10, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT05282953
A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS)
PHASE1/PHASE2Recruiting
12 participants
Started: Nov 10, 2022 · Completed: Jul 31, 2026
2 conditions1 sponsor2 locations
NCT06801262
TreaT-Assay: the New Frontier for the Diagnosis of Acute Rejection in Kidney Transplantation
N/ARecruiting
150 participants
Started: Nov 10, 2022 · Completed: May 1, 2026
3 conditions1 sponsor1 location
NCT05173844
Digital Sleep Therapy for Older Adults with Cognitive Impairment
NAActive, not recruiting
128 participants
Started: Nov 10, 2022 · Completed: Apr 15, 2025
2 conditions1 sponsor1 location
NCT05669495
ANNE Vital Sign System Remote Sleep Assessment
N/ARecruiting
750 participants
Started: Nov 10, 2022 · Completed: Oct 31, 2025
4 conditions2 sponsors1 location
NCT05306834
Stopping Cognitive Decline and Dementia by Fighting Covert Cerebral Small Vessel Disease
NARecruiting
400 participants
Started: Nov 10, 2022 · Completed: Nov 30, 2027
3 conditions1 sponsor2 locations
NCT05635227
Dexamethasone, Olanzapine, Hemodynamics, and Ventilation in Cardiac Surgery
NARecruiting
1,200 participants
Started: Nov 10, 2022 · Completed: Feb 29, 2028
2 conditions1 sponsor1 location
NCT05603741
Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers
PHASE4Active, not recruiting
155 participants
Started: Nov 10, 2022 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT06435403
SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia
N/ARecruiting
1,000 participants
Started: Nov 10, 2022 · Completed: Feb 28, 2025
3 conditions3 sponsors2 locations